Pharmgate concludes acquisition of Pennfield Animal Health

November 3, 2014 - Pharmgate LLC today announced that it has successfully concluded the acquisition of Pennfield Animal Health and is open for business with the same customer service and account representatives as before. Manufacturing, laboratory, regulatory, accounting and customer service functions remain in Omaha Nebraska. The products will be sold and serviced under the Pharmgate Animal Health banner.

Edward Seed, General Manager, says, “We are fortunate to merge a product line and experienced sales and service organization that will be largely complementary with our own. The nature of the companies’ respective products, marketing models and customer segments, will permit a healthy degree of sales synergy. After a successful start with Aivlosin®, the addition of the Pennchlor®, Pennox® and Neo-Oxy® products gives us the critical mass and marketing presence needed to better satisfy a broader range of customer needs, and positions us well with a range of therapeutic antibiotics. Customers can expect the desired degree of product supply and service post-closing.”

About Pharmgate LLC
Pharmgate LLC is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., P. R. China, the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride, salinomycin and other animal health compounds. The company has marketing or supply approvals for these products in most major markets throughout the world.

Pharmgate Animal Health LLC is the joint venture between Pharmgate LLC and ECO Animal Health, London U.K., a leader in the development, registration and marketing of pharmaceutical products for global animal health markets including Aivlosin®, as well as a range of branded generic animal health therapeutic products.

Aivlosin® is the registered trademark of ECO Animal Health Ltd.

Pennchlor®, Pennox® and Neo-Oxy® are the registered trademarks of Pennfield Oil Company, Inc.

Contact: Edward Seed +1 201 237 3800


View Labels »


Visit Website »


  • October 12, 2016 Pharmgate concludes merger with ProtaTek International, Inc.

    September 15, 2016 Pharmgate announces agreement to acquire ProtaTek International, Inc.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

    August 1, 2016 - Pharmgate announces new appointments.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

  • November 25, 2013 - Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.

    August 13, 2015 - Pharmgate is pleased to announce the relocation of its headquarters from Ramsey, New Jersey to Wilmington, North Carolina.

  • March 17, 2014 - Pharmgate Animal Health announces the Canadian launch of Aivlosin® 17% Tylvalosin Medicated Premix for the treatment of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine

    August 8, 2013 - Pharmgate acquires chlortetracycline product licenses in Latin America.

  • August 1, 2014 - ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce...

    August 1, 2014 - Pharmgate Animal Health announces two Sales and Marketing appointments.

  • November 3, 2014 - Pharmgate concludes acquisition of Pennfield Animal Health

    October 16, 2014 - Pharmgate announces agreement to acquire the assets of Pennfield Animal Health.


Pharmgate Animal Health LLC
1800 Sir Tyler Drive
Wilmington, NC 28405
Tel: 1-800-380-6099
Fax: 910-679-8368

Pharmgate Animal Health Canada, Inc.
5204 Tenth Line, R.R. #2
Erin, Ontario N0B 1T0
Tel: 1-800-465-2450
Fax: 910-679-8368